News

Applied Materials(NASDAQ:AMAT) reported third-quarter fiscal 2025 results on August 14, 2025, delivering record quarterly revenue of $7.3 billion (up 8% year over year), record non-GAAP earnings per

Eledon Pharmaceuticals (NASDAQ:ELDN), a biotechnology company focused on developing novel therapies for organ and cell transplantation as well as amyotrophic lateral sclerosis (ALS), issued its

Applied Materials (NASDAQ:AMAT), a leading supplier of materials engineering solutions for the semiconductor and display industries, reported its fiscal third-quarter results on Aug. 14, 2025. The

Strattec Security (NASDAQ:STRT), a leading designer and manufacturer of mechanical and electronic locks and access control products for the automotive industry, released its fourth quarter fiscal

RenovoRx (NASDAQ:RNXT), a medical technology company focused on targeted cancer therapy delivery, reported earnings on August 14, 2025. As sales of its RenovoCath device grew to $422,000 (GAAP)

SWK (NASDAQ:SWKH), a specialty finance company targeting the healthcare sector, announced its second quarter 2025 results on August 14, 2025. The most notable headline is that its non-GAAP adjusted

Phio Pharmaceuticals (NASDAQ:PHIO), a biotechnology company developing gene-silencing therapies for cancer, released its second quarter 2025 results on August 14, 2025. The quarter’s key news

Talphera (NASDAQ:TLPH), a specialty pharmaceutical company developing therapies for medically supervised hospital settings, reported its second quarter 2025 results on August 14, 2025. The company

Arcadia Biosciences (NASDAQ:RKDA), a consumer wellness beverage company known for the Zola coconut water brand, released its second quarter results on August 14, 2025. The company reported GAAP

Plus Therapeutics (NASDAQ:PSTV), a clinical-stage biotech focused on radiotherapeutics and diagnostics for central nervous system cancers, reported its second quarter 2025 results on August 14

Annexon (NASDAQ:ANNX), a clinical-stage biopharmaceutical company developing therapies for serious autoimmune and neurodegenerative diseases, released its second quarter 2025 financial results on

bioAffinity Technologies (NASDAQ:BIAF), a biotechnology company focused on noninvasive diagnostics and cancer therapeutics, reported results for Q2 2025 on August 14, 2025. The most significant news

Reading International (NASDAQ:RDI), an operator of cinemas and real estate properties across the United States, Australia, and New Zealand, reported its second quarter fiscal 2025 results on August

P3 Health Partners (NASDAQ:PIII), a physician-led healthcare group focused on value-based care for Medicare Advantage members, reported results for Q2 FY2025 on August 14, 2025. The most notable

Celcuity (NASDAQ:CELC), a clinical-stage biotechnology company developing targeted therapies for cancer, released its second quarter 2025 earnings on August 14, 2025. The highlight was topline Phase

Co-Diagnostics (NASDAQ:CODX), a diagnostics technology company focused on infectious disease testing, announced its Q2 2025 results on August 14, 2025. GAAP EPS loss of $0.23 was better than

Daré Bioscience (NASDAQ:DARE), a women’s health-focused biopharmaceutical company developing new therapies and devices, announced its second quarter 2025 results on August 14, 2025. The headline

Shares of department store company Dillard's (NYSE: DDS) rallied on Thursday, up 5.4% as of 2 p.m. ET.

Dillard's reported second-quarter earnings that, while certainly not eye-opening from a growth

Advance Auto Parts(NYSE:AAP) reported second-quarter 2025 results on Aug. 14, 2025, with GAAP net sales of $2 billion, down 8% year-over-year, and adjusted earnings per share (EPS) of $0.69. The

Amcor(NYSE:AMCR) reported fiscal fourth quarter 2025 results on August 14, 2025, highlighting the completed Berry Global acquisition, new synergy targets, and a comprehensive portfolio review

Shares of leading enterprise software provider Nice (NASDAQ: NICE) had dropped 7% as of 11 a.m. ET on Thursday, according to data provided by S&P Global Market Intelligence. Nice reported

Applied Industrial Technologies(NYSE:AIT) reported its fiscal fourth quarter ended June 30, 2025, earnings on August 14, 2025, delivering record full-year sales, EBITDA, and EPS for the fiscal year

An inflation spike coming out of the coronavirus pandemic helped to boost the profits of energy companies. But after hitting a peak, oil and natural gas prices have come back down. That has taken

Ideal Power (NASDAQ:IPWR), a developer of efficient power semiconductor devices, published its second quarter 2025 results on August 14, 2025. The most notable news from the earnings release was a

Applied Industrial Technologies (NYSE:AIT), a major distributor of industrial motion, fluid power, and automation components, reported its fiscal fourth quarter 2025 results on August 14, 2025. The